65,437 trials
Type 2 Diabetes
Primary: Adjusted Change From Baseline in Glycated Hemoglobin A1c (HbA1c) at Week 28 — 0.11; 0.38 percentage (%HbA1c) — p=0.444
Osteoporosis, Postmenopausal · Periodontitis
Primary: Sost Values for 6th Month — 1389.177; 1085.405; 1596.585; 2131.87 ng/ml — p=<0.01
Epilepsy
Primary: AUC — 101346; 101393 ng*hr/ml
Osteoarthritis, Hip
Primary: Number of Patients With Successful Study Drug Administrations — 12 Participants
Hearing Loss
Primary: Change in Open Set Monosyllabic Word Recognition Score as Measured on a Consonant Nucleus Consonant (CNC) Word Test — 54.7 percentage correct
Glaucoma, Primary Open Angle · Ocular Hypertension
Primary: Intraocular Pressure — 18.20; 18.44 mm Hg
Pain
Primary: Area Under the Curve (AUC) of Visual Analog Scale (VAS) Pain Intensity Scores Through 72 Hours — 259.545; 250.998; 279.794 cm*hr — p=0.4463
Intra Abdominal Infections
Primary: Percentage of Participants With Clinical Success — 85.5; 90.2 percentage of participants
Healthy
Primary: Degree of Forarm Rotation With Thermoplastic Ulnar Based Muenster Orthosis, Delta-Cast Orthosis and Hely and Weber Fracture Brace MTC — 88.4; 49.1; 67.2 degrees
Hemorrhagic Fever With Renal Syndrome
Primary: Number of Participants With Seroconversion of HTNV and PUUV Using PsVNA50 — 1; 1; 1; 2 Participants
Kidney Transplantation
Primary: Number of Participants With Graft Survival at 12 Months — 18; 12 Participants
Vitiligo
Primary: Mean Change From Baseline in Facial Depigmentation in the AOI (Area of Interest) Based on Canfield 2-D Photographic Analysis From Baseline to Week 24 — 2.0 score on a…
Pulmonary Disease, Chronic Obstructive
Primary: Incidence Rate of Chronic Obstructive Pulmonary Disease (COPD) Exacerbation — 1.32; 1.14 Events per 1000 person-days
COPD
Primary: Incidence Rate of Chronic Obstructive Pulmonary Disease (COPD) Exacerbation — 1.63; 2.43 Events per 1,000 Person-days
Influenza
Primary: Time to Clinical Improvement — 97.5; 100.2 hours — p=0.4666